Santa Monica, CA, United States of America

Paul Kavanagh

This inventor holds 2 USPTO granted patents. Top assignee: Cedars-Sinai Medical Center. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Kavanagh. Retrieved from https://idiyas.com/inventor/paul-kavanagh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul Kavanagh: Innovator in Cardiac Assessment Technologies

Introduction

Paul Kavanagh is a notable inventor based in Santa Monica, CA. He has made significant contributions to the field of cardiac health, particularly in the assessment of transthyretin amyloid cardiomyopathy (ATTR-CM). His innovative approach has the potential to enhance diagnostic accuracy and patient outcomes.

Latest Patents

Kavanagh holds a patent for "Systems and methods for the assessment of cardiac amyloidosis." This patent outlines a method for calculating a cardiac pyrophosphate activity (CPA) measurement from single-photon emission computed tomography (SPECT) images. The process involves analyzing SPECT images obtained using Technetium-pyrophosphate as a radiotracer to determine abnormal myocardial activity. The CPA measurement is calculated based on the mean radiotracer counts in regions of abnormal activity, providing a valuable assessment tool for ATTR-CM.

Career Highlights

Paul Kavanagh is affiliated with Cedars-Sinai Medical Center, where he applies his expertise in cardiac imaging and diagnostics. His work focuses on improving methodologies for assessing cardiac conditions, which is crucial for timely and effective treatment.

Collaborations

Kavanagh collaborates with esteemed colleagues such as Piotr Slomka and Sebastien Cadet. Their combined efforts contribute to advancing research and innovation in cardiac health.

Conclusion

Paul Kavanagh's contributions to cardiac assessment technologies exemplify the impact of innovation in healthcare. His patent and ongoing work at Cedars-Sinai Medical Center highlight the importance of advancing diagnostic methods for better patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…